Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1976 Sep 18;2(6037):669–671. doi: 10.1136/bmj.2.6037.669

Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B.

I L Woolf, N El Sheikh, H Cullens, W M Lee, A L Eddleston, R Williams, A J Zuckerman
PMCID: PMC1688339  PMID: 974529

Abstract

The possible importance of humoral immunity in the pathogenesis of fulminant hepatitis was investigated by comparing 17 patients with fulminant hepatitis type B with 20 patients with severe but non-fulminant disease. Hepatitis B surface antigen (HBsAg) was cleared from the serum significantly faster (P less than 0-001) in those with fulminant hepatitis, and in 41% anti-HBsAg (HBsAb) was detectable by radioimmunoassay (RIA) at presentation. In all 11 sera from patients with fulminant hepatitis that were examined by electron microscopy aggregates of HBsAg and HBsAb were seen. In contrast, HBsAb was never detected by RIA in those with non-fulminant hepatitis, and in only one serum specimen (5%) were aggregates seen on electron microscopy. A significant sex difference between fulminant and non-fulminant hepatitis was observed, 65% of patients with fulminant hepatitis but only 15% of patients with non-fulminant hepatitis being women (P less than 0-01). An enhanced production of HBsAb in fulminant hepatitis, by leading to free HBsAb in portal blood, may cause an Arthus reaction in the sinusoids of the liver with ensuing ischaemic necrosis of hepatocytes.

Full text

PDF
669

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almeida J. D., Waterson A. P. Immune complexes in hepatitis. Lancet. 1969 Nov 8;2(7628):983–986. doi: 10.1016/s0140-6736(69)90540-6. [DOI] [PubMed] [Google Scholar]
  2. Barker L. F., Peterson M. R., Shulman N. R., Murray R. Antibody responses in viral hepatitis, type B. JAMA. 1973 Feb 26;223(9):1005–1008. [PubMed] [Google Scholar]
  3. Blumberg B. S., Sutnick A. I., London W. T., Melartin L. Sex distribution of Australia antigen. Arch Intern Med. 1972 Aug;130(2):227–231. [PubMed] [Google Scholar]
  4. Boughton C. R. Viral hepatitis in Sydney: a review of fatal illnesses in a hospital series. Med J Aust. 1968 Aug 24;2(8):343–350. doi: 10.5694/j.1326-5377.1968.tb82821.x. [DOI] [PubMed] [Google Scholar]
  5. Dudley F. J., Fox R. A., Sherlock S. Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet. 1972 Apr 1;1(7753):723–726. doi: 10.1016/s0140-6736(72)90234-6. [DOI] [PubMed] [Google Scholar]
  6. Galbraith R. M., Eddleston A. L., Williams R., Zuckerman A. J. Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet. 1975 Sep 20;2(7934):528–530. doi: 10.1016/s0140-6736(75)90897-1. [DOI] [PubMed] [Google Scholar]
  7. Jameson R. M. Prolonged survival in paraplegia due to metastatic spinal tumours. Lancet. 1974 Jun 15;1(7868):1209–1211. doi: 10.1016/s0140-6736(74)91016-2. [DOI] [PubMed] [Google Scholar]
  8. Nielsen J. O., Le Bouvier G. L. Subtypes of Australia antigen among patients and healthy carriers in Copenhagen. A relation between the subtypes and the degree of liver damage in acute viral hepatitis. N Engl J Med. 1973 Jun 14;288(24):1257–1261. doi: 10.1056/NEJM197306142882401. [DOI] [PubMed] [Google Scholar]
  9. ROWLEY D. A. The formation of circulating antibody in the splenectomized human being following intravenous injection of heterologous erythrocytes. J Immunol. 1950 Nov;65(5):515–521. [PubMed] [Google Scholar]
  10. Reed W. D., Mitchell C. G., Eddleston A. L., Lee W. M., Williams R., Zuckerman A. J. Exposure and immunity to hepatitis-B virus in a liver unit. Lancet. 1974 Apr 6;1(7858):581–583. doi: 10.1016/s0140-6736(74)92646-4. [DOI] [PubMed] [Google Scholar]
  11. Sherlock S. Long-incubation (virus B, HAA-associated) hepatitis. Gut. 1972 Apr;13(4):297–307. doi: 10.1136/gut.13.4.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Shulman N. R. Hepatitis-associated antigen. Am J Med. 1970 Nov;49:669–692. doi: 10.1016/S0002-9343(70)80133-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Trepo C. G., Robert D., Motin J., Trepo D., Sepetjian M., Prince A. M. Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance. Gut. 1976 Jan;17(1):10–13. doi: 10.1136/gut.17.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES